about
sameAs
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.Neuroimaging in moderate MDMA use: A systematic reviewNutritional aspects of depressionEffects of cannabis on impulsivity: a systematic review of neuroimaging findingsIs cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic usersApproaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future researchEffects of cortisol administration on craving in heroin addictsAssociation of cognitive impairment and lesion volumes in multiple sclerosis--a MRI study.Alterations in the hippocampus and thalamus in individuals at high risk for psychosis.Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI studyGray matter volumetric abnormalities associated with the onset of psychosis.Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients.The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data.Sex Effects on Smoking Cue Perception in Non-Smokers, Smokers, and Ex-Smokers: A Pilot StudyBDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.Counter striking psychosis: Commercial video games as potential treatment in schizophrenia? A systematic review of neuroimaging studies.Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis.Gut Taste Stimulants Alter Brain Activity in Areas Related to Working Memory: a Pilot Study.Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.Differential effects of L-tryptophan and L-leucine administration on brain resting state functional networks and plasma hormone levels.Hippocampal volume in subjects at clinical high-risk for psychosis: A systematic review and meta-analysis.Neuroimaging in cannabis use: a systematic review of the literature.The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis.Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigationsNeuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.Structural Network Disorganization in Subjects at Clinical High Risk for Psychosis.Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk stateA Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disordersNeuroimaging and resilience factors--staging of the at-risk mental state?Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies.Cognitive functioning in prodromal psychosis: a meta-analysis.Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studiesMultimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication.Resting state abnormalities in psychosis compared to acute cannabinoids and opioids challenges: a systematic review of functional imaging studies.Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysisWhite matter pathology--an endophenotype for bipolar disorder?
P50
Q24602238-1C91044D-2370-4D25-8389-C0AEE9F5E679Q26770106-0A7FE0E5-577E-41B2-B62D-802C366D4C4EQ26781553-5DE09341-07A0-43FB-98F7-77EEC45B8777Q27001542-00BEB359-6142-40A0-A908-3DB79A66B885Q27021991-73AB9211-2DBE-49B4-9DF0-814026F590D7Q28081379-A1654799-6CE8-4B4B-B9FB-8AFE35FF9D36Q29396174-BF17159A-CFB2-448B-BE5B-50F7C2B5AA55Q30369253-104A12AD-55D2-450D-81FA-A883BB3BA9D7Q30381309-C582AFE0-8F0C-4F86-B01E-E9691D5610A6Q30467197-2E3ADDEE-4D8E-4DB0-A555-626D82C33748Q30580970-65EB416A-F5C3-4675-A272-2147330C20C2Q30640803-54C7E167-3F85-4192-AF43-2F18C2FF964AQ30787015-F4A9A2C8-108B-402F-9631-A0381A67AA44Q30828909-3C661968-0975-4B58-81B7-F09F93E4DCBBQ30947753-0813BC79-21C0-4EBC-B061-9DB4E2F01523Q31080277-81C23355-F98E-496C-92EE-F64B64AB140EQ31092643-590A9DC6-F5E4-4CDF-9DF1-E757759DD3C8Q31117648-39113C56-DF2E-4FCE-90F0-C3FF900D0A0FQ31122156-9710EDCC-CA62-4AE5-AAF8-60163F9716F6Q31137814-EF3B0735-94FA-493B-BF9D-D61BDA89950DQ31138553-8398E006-846D-434C-A0C6-1D3E0716A4E6Q33486183-f28bc08a-423e-1f7a-63fa-7a0ccbf74a94Q33494667-2F7FDAED-D4AA-41EC-8187-4A51574ADAAAQ33530424-4E8B1995-BA26-4A98-86DE-8008ED08FDD2Q33635662-CD07C5C7-2BDC-4E64-AF48-2A021D3380EFQ33762566-33786D50-4EAA-4986-8765-4D0B31C969FFQ33775024-13B0BC54-050B-4A1D-A8A8-A8F42C4E56D4Q33777660-9B9E722D-88CF-4FBB-BE1F-E1F7701B0C14Q33817901-433B6BEE-ABCA-4D99-A8C0-17A4E774EACBQ33843524-D14BE1AC-F0F6-4AE4-89AA-F7084C8C2766Q34048584-59E7A412-51B8-4584-9D3C-44F65AFF03D1Q34125575-FCAE8F1E-AE33-4379-AC3E-AEC247FD646FQ34148363-8DDFFF87-630D-4948-A7FF-E70945D19975Q34278910-BC7E6EAE-6BF6-4980-BC59-195708DDE473Q34282907-B61DAE68-CCB8-4D66-BCAC-D73E4EC86914Q34295212-D90B5E2C-3BC4-47FD-BB6C-13E5D8F4F7E9Q34310765-B0E56C0F-0484-44E8-A91B-91C0C716542FQ34351095-C81DF0E9-2592-48FB-9849-E1A5D5F6EC1AQ34393431-C6E3D952-6E24-49A7-85F8-B80BDC2E2152Q34413111-FAA9F42C-119E-4092-AF18-6EC20B4694DA
P50
subject
description
medico
@it
médico
@pt-br
onderzoeker
@nl
physician
@en
name
Stefan Borgwardt
@es
Stefan J Borgwardt
@en
Stefan J Borgwardt
@nl
Stefan J Borgwardt
@pt-br
Stefan J Borgwardt
@sl
type
label
Stefan Borgwardt
@es
Stefan J Borgwardt
@en
Stefan J Borgwardt
@nl
Stefan J Borgwardt
@pt-br
Stefan J Borgwardt
@sl
altLabel
Stefan Borgwardt
@en
Stefan J. Borgwardt
@en
prefLabel
Stefan Borgwardt
@es
Stefan J Borgwardt
@en
Stefan J Borgwardt
@nl
Stefan J Borgwardt
@pt-br
Stefan J Borgwardt
@sl
P1006
P1015
P214
P227
P244
P1006
P1015
P106
P1153
12240845100
P1960
j-Gy4CsAAAAJ
P2038
Stefan_Borgwardt
P21
P213
0000 0001 1903 8971
P214
P227
1159718296
P244
n2011181561